AR and prostate cancer: To further explore the association of TLX and AR expression in primary prostate cancer and CRPC, we compared TLX levels in ARlow and ARhigh subsets of prostate cancer patients using RNA-seq datasets in two published cohorts [19, 38] in an unbiased manner.